Security record · archived quarter
SOLV
Solventum Corporation · Healthcare · Medical - Instruments & Supplies
16Tracked holders
—Δ holders
16.58MShares held
$874.59MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 151 | +2 | 80.32M | $6.20B | +13 | −10 |
| Q1 2026 | 151 | -8 | 79.93M | $5.22B | +3 | −12 |
| Q4 2025 | 158 | +1 | 87.71M | $6.95B | +3 | −1 |
| Q3 2025 | 22 | +1 | 55.78M | $4.07B | +1 | −1 |
| Q2 2025 | 19 | 0 | 51.64M | $3.92B | +2 | −2 |
| Q1 2025 | 16 | -1 | 25.10M | $1.91B | +1 | −2 |
| Q4 2024 | 17 | -2 | 26.13M | $1.73B | +2 | −4 |
| Q3 2024 | 18 | +2 | 20.00M | $1.39B | +4 | −2 |
| Q2 2024 | 16 | — | 16.58M | $874.59M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Trian Fund Management ✦ | 5.36M | — | $283.47M | 6.9% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 3.22M | — | $169.77M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.22M | — | $169.77M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 2.59M | — | $136.92M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Baupost Group ✦ | 1.82M | — | $96.24M | 2.7% | n/c | 1 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 1.22M | — | $62.62M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 1.22M | — | $62.62M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.22M | — | $62.62M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 1.22M | — | $62.62M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 765.77K | — | $40.49M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 392.05K | — | $20.73M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Capital World Investors ✦ | 391.22K | — | $20.69M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 276.92K | — | $14.64M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 276.92K | — | $14.64M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 200.06K | — | $10.58M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 200.06K | — | $10.58M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 163.97K | — | $8.67M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Markel Group ✦ | 73.44K | — | $3.88M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Markel Group ✦ | 73.44K | — | $3.88M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 54.87K | — | $2.90M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 30.00K | — | $1.59M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 21.67K | — | $1.15M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Wellington Management ✦ | 21.67K | — | $1.15M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | GAMCO Investors ✦ | 4.68K | — | $247,690 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 873 holders, 128.07M shares, $8.18B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API